Aeglea BioTherapeutics Investor Presentation Deck

SPY002 is designed to achieve an optimal anti-TL1A product profile SPYRE DUAL MONOMER AND TRIMER BINDING PICOMOLAR POTENCY AGAINST MONOMERS & TRIMERS FULLY SC, EXTENDED HALF-LIFE mAb PREDICTED TO ENABLE Q8-12W DOSING 21

View entire presentation